NR3C1 and asthma: Importantly, glucocorticosteroids (GCS), the mainstay of current asthma treatment, have markedly reduced anti-inflammatory effects on myofibroblasts13, which may be at least in part, due to the increased levels of the inactive isoform of glucocorticoid receptor (GRβ) in myofibroblasts14.